Selected research
Industry Growth & Trends
Global Cytotoxicity Testing Services Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Cytotoxicity Testing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Cytotoxicity Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Cytotoxicity Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cytotoxicity Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Cytotoxicity Testing Services market include Sartorius, Eurofins Scientific, TÜV SÜD, Nelson Labs, Pacific BioLabs, Emery Pharma, UFAG Laboratorien AG, NorthEast BioLab and Biosafe Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Cytotoxicity Testing Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Cytotoxicity Testing Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cytotoxicity Testing Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cytotoxicity Testing Services.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Cytotoxicity Testing Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Cytotoxicity Testing Services Market by Company
Sartorius
Eurofins Scientific
TÜV SÜD
Nelson Labs
Pacific BioLabs
Emery Pharma
UFAG Laboratorien AG
NorthEast BioLab
Biosafe Ltd
Creative Bioarray
Evercyte
IONTOX
Applied StemCell
Xenometrix AG
Medicilon
UL
SGS
iuvo BioScience
Cytotoxicity Testing Services Segment by Type
Elution Testing Method
Agar Overlay Method
Direct Contact Method
MTT Assay Method
Others
Cytotoxicity Testing Services Segment by Application
Drug
Medical Instruments
Cosmetics and Personal Care
Others
Cytotoxicity Testing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cytotoxicity Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cytotoxicity Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cytotoxicity Testing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Cytotoxicity Testing Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Elution Testing Method
- Agar Overlay Method
- Direct Contact Method
- MTT Assay Method
- Others
Applications
- Drug
- Medical Instruments
- Cosmetics and Personal Care
- Others
Companies covered
- Sartorius
- Eurofins Scientific
- TÜV SÜD
- Nelson Labs
- Pacific BioLabs
- Emery Pharma
- UFAG Laboratorien AG
- NorthEast BioLab
- Biosafe Ltd
- Creative Bioarray
- Evercyte
- IONTOX
- Applied StemCell
- Xenometrix AG
- Medicilon
- UL
- SGS
- iuvo BioScience
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Cytotoxicity Testing Services Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Cytotoxicity Testing Services Market Size by Region (2021-2032)
- 1.4.1 Global Cytotoxicity Testing Services Market Size by Region (2021-2026)
- 1.4.2 Global Cytotoxicity Testing Services Market Size by Region (2027-2032)
- 1.5 Key Regions Cytotoxicity Testing Services Market Size (2021-2032)
- 1.5.1 North America Cytotoxicity Testing Services Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Cytotoxicity Testing Services Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Cytotoxicity Testing Services Market Size Growth Rate (2021-2032)
- 1.5.4 South America Cytotoxicity Testing Services Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Cytotoxicity Testing Services Market Size Growth Rate (2021-2032)
2 Cytotoxicity Testing Services Market by Type
- 2.1 Type Introduction
- 2.1.1 Elution Testing Method
- 2.1.2 Agar Overlay Method
- 2.1.3 Direct Contact Method
- 2.1.4 MTT Assay Method
- 2.1.5 Others
- 2.2 Global Cytotoxicity Testing Services Market Size by Type
- 2.2.1 Global Cytotoxicity Testing Services Market Size Overview by Type (2021-2032)
- 2.2.2 Global Cytotoxicity Testing Services Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Cytotoxicity Testing Services Market Size Forecasted by Type (2027-2032)
- 2.3 Global Cytotoxicity Testing Services Market Size by Regions
- 2.3.1 North America Cytotoxicity Testing Services Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Cytotoxicity Testing Services Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Cytotoxicity Testing Services Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Cytotoxicity Testing Services Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Cytotoxicity Testing Services Market Size Breakdown by Type (2021-2026)
3 Cytotoxicity Testing Services Market by Application
- 3.1 Type Introduction
- 3.1.1 Drug
- 3.1.2 Medical Instruments
- 3.1.3 Cosmetics and Personal Care
- 3.1.4 Others
- 3.2 Global Cytotoxicity Testing Services Market Size by Application
- 3.2.1 Global Cytotoxicity Testing Services Market Size Overview by Application (2021-2032)
- 3.2.2 Global Cytotoxicity Testing Services Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Cytotoxicity Testing Services Market Size Forecasted by Application (2027-2032)
- 3.3 Global Cytotoxicity Testing Services Market Size by Regions
- 3.3.1 North America Cytotoxicity Testing Services Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Cytotoxicity Testing Services Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Cytotoxicity Testing Services Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Cytotoxicity Testing Services Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Cytotoxicity Testing Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Cytotoxicity Testing Services Industry Trends
- 4.2 Cytotoxicity Testing Services Industry Drivers
- 4.3 Cytotoxicity Testing Services Industry Opportunities and Challenges
- 4.4 Cytotoxicity Testing Services Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Cytotoxicity Testing Services Revenue (2021-2026)
- 5.2 Global Cytotoxicity Testing Services Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Cytotoxicity Testing Services Key Company Headquarters & Area Served
- 5.4 Global Cytotoxicity Testing Services Company, Product Type & Application
- 5.5 Global Cytotoxicity Testing Services Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Cytotoxicity Testing Services Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Cytotoxicity Testing Services Players Market Share by Revenue in 2025
- 5.6.3 2025 Cytotoxicity Testing Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Sartorius
- 6.1.1 Sartorius Company Information
- 6.1.2 Sartorius Business Overview
- 6.1.3 Sartorius Cytotoxicity Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Sartorius Cytotoxicity Testing Services Product Portfolio
- 6.1.5 Sartorius Recent Developments
- 6.2 Eurofins Scientific
- 6.2.1 Eurofins Scientific Company Information
- 6.2.2 Eurofins Scientific Business Overview
- 6.2.3 Eurofins Scientific Cytotoxicity Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Eurofins Scientific Cytotoxicity Testing Services Product Portfolio
- 6.2.5 Eurofins Scientific Recent Developments
- 6.3 TÜV SÜD
- 6.3.1 TÜV SÜD Company Information
- 6.3.2 TÜV SÜD Business Overview
- 6.3.3 TÜV SÜD Cytotoxicity Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 TÜV SÜD Cytotoxicity Testing Services Product Portfolio
- 6.3.5 TÜV SÜD Recent Developments
- 6.4 Nelson Labs
- 6.4.1 Nelson Labs Company Information
- 6.4.2 Nelson Labs Business Overview
- 6.4.3 Nelson Labs Cytotoxicity Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Nelson Labs Cytotoxicity Testing Services Product Portfolio
- 6.4.5 Nelson Labs Recent Developments
- 6.5 Pacific BioLabs
- 6.5.1 Pacific BioLabs Company Information
- 6.5.2 Pacific BioLabs Business Overview
- 6.5.3 Pacific BioLabs Cytotoxicity Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Pacific BioLabs Cytotoxicity Testing Services Product Portfolio
- 6.5.5 Pacific BioLabs Recent Developments
- 6.6 Emery Pharma
- 6.6.1 Emery Pharma Company Information
- 6.6.2 Emery Pharma Business Overview
- 6.6.3 Emery Pharma Cytotoxicity Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Emery Pharma Cytotoxicity Testing Services Product Portfolio
- 6.6.5 Emery Pharma Recent Developments
- 6.7 UFAG Laboratorien AG
- 6.7.1 UFAG Laboratorien AG Company Information
- 6.7.2 UFAG Laboratorien AG Business Overview
- 6.7.3 UFAG Laboratorien AG Cytotoxicity Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 UFAG Laboratorien AG Cytotoxicity Testing Services Product Portfolio
- 6.7.5 UFAG Laboratorien AG Recent Developments
- 6.8 NorthEast BioLab
- 6.8.1 NorthEast BioLab Company Information
- 6.8.2 NorthEast BioLab Business Overview
- 6.8.3 NorthEast BioLab Cytotoxicity Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 NorthEast BioLab Cytotoxicity Testing Services Product Portfolio
- 6.8.5 NorthEast BioLab Recent Developments
- 6.9 Biosafe Ltd
- 6.9.1 Biosafe Ltd Company Information
- 6.9.2 Biosafe Ltd Business Overview
- 6.9.3 Biosafe Ltd Cytotoxicity Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Biosafe Ltd Cytotoxicity Testing Services Product Portfolio
- 6.9.5 Biosafe Ltd Recent Developments
- 6.10 Creative Bioarray
- 6.10.1 Creative Bioarray Company Information
- 6.10.2 Creative Bioarray Business Overview
- 6.10.3 Creative Bioarray Cytotoxicity Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Creative Bioarray Cytotoxicity Testing Services Product Portfolio
- 6.10.5 Creative Bioarray Recent Developments
- 6.11 Evercyte
- 6.11.1 Evercyte Company Information
- 6.11.2 Evercyte Business Overview
- 6.11.3 Evercyte Cytotoxicity Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Evercyte Cytotoxicity Testing Services Product Portfolio
- 6.11.5 Evercyte Recent Developments
- 6.12 IONTOX
- 6.12.1 IONTOX Company Information
- 6.12.2 IONTOX Business Overview
- 6.12.3 IONTOX Cytotoxicity Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 IONTOX Cytotoxicity Testing Services Product Portfolio
- 6.12.5 IONTOX Recent Developments
- 6.13 Applied StemCell
- 6.13.1 Applied StemCell Company Information
- 6.13.2 Applied StemCell Business Overview
- 6.13.3 Applied StemCell Cytotoxicity Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Applied StemCell Cytotoxicity Testing Services Product Portfolio
- 6.13.5 Applied StemCell Recent Developments
- 6.14 Xenometrix AG
- 6.14.1 Xenometrix AG Company Information
- 6.14.2 Xenometrix AG Business Overview
- 6.14.3 Xenometrix AG Cytotoxicity Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Xenometrix AG Cytotoxicity Testing Services Product Portfolio
- 6.14.5 Xenometrix AG Recent Developments
- 6.15 Medicilon
- 6.15.1 Medicilon Company Information
- 6.15.2 Medicilon Business Overview
- 6.15.3 Medicilon Cytotoxicity Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Medicilon Cytotoxicity Testing Services Product Portfolio
- 6.15.5 Medicilon Recent Developments
- 6.16 UL
- 6.16.1 UL Company Information
- 6.16.2 UL Business Overview
- 6.16.3 UL Cytotoxicity Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 UL Cytotoxicity Testing Services Product Portfolio
- 6.16.5 UL Recent Developments
- 6.17 SGS
- 6.17.1 SGS Company Information
- 6.17.2 SGS Business Overview
- 6.17.3 SGS Cytotoxicity Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 SGS Cytotoxicity Testing Services Product Portfolio
- 6.17.5 SGS Recent Developments
- 6.18 iuvo BioScience
- 6.18.1 iuvo BioScience Company Information
- 6.18.2 iuvo BioScience Business Overview
- 6.18.3 iuvo BioScience Cytotoxicity Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 iuvo BioScience Cytotoxicity Testing Services Product Portfolio
- 6.18.5 iuvo BioScience Recent Developments
7 North America
- 7.1 North America Cytotoxicity Testing Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Cytotoxicity Testing Services Market Size by Country (2021-2026)
- 7.3 North America Cytotoxicity Testing Services Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Cytotoxicity Testing Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Cytotoxicity Testing Services Market Size by Country (2021-2026)
- 8.3 Europe Cytotoxicity Testing Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Cytotoxicity Testing Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Cytotoxicity Testing Services Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Cytotoxicity Testing Services Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Cytotoxicity Testing Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Cytotoxicity Testing Services Market Size by Country (2021-2026)
- 10.3 South America Cytotoxicity Testing Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Cytotoxicity Testing Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Cytotoxicity Testing Services Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Cytotoxicity Testing Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst